BCM
PMD

Brookstone Capital Management’s Psychemedics Corporation PMD Stock Holding History

Brookstone Capital Management’s Portfolio PMD Stock Details PMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-78
Closed -$1K – 2173
2015
Q2 		$1K Buy
+78
New +$1.22K ﹤0.01% 2033

Other funds holding PMD

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
NSIM
North Star Investment Management Chicago, Illinois $1.65B AUM 20.56% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
CIC
Crawford Investment Counsel Atlanta, Georgia $5.85B AUM 12.61% 1-Year Est. Return
MC
Moors & Cabot Boston, Massachusetts $2.34B AUM 30.42% 1-Year Est. Return
KFA
Kelleher Financial Advisors New York $395M AUM 12.89% 1-Year Est. Return

Brookstone Capital Management's PMD Position: Q3 2015 in Review

Brookstone Capital Management sold out of Psychemedics Corporation (PMD) in Q3 2015, closing a stake of 78 shares — an estimated $1K sold.

Brookstone Capital Management first reported a position in PMD in Q2 2015 and held it in 1 quarter. The position peaked at $1K in Q2 2015. 38 funds tracked by Wall St. Rank hold PMD as of Q3 2015.

  • Brookstone Capital Management reported no remaining Psychemedics Corporation position as of Q3 2015 after selling out during the quarter.
  • Brookstone Capital Management sold 78 Psychemedics Corporation shares in Q3 2015, an estimated $1K.
  • Brookstone Capital Management first reported a position in Psychemedics Corporation in Q2 2015 and held it in 1 quarter.
  • Brookstone Capital Management's Psychemedics Corporation position peaked at $1K in Q2 2015.
  • 38 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q3 2015.

Based on Brookstone Capital Management's 13F filing for Q3 2015, filed 28 Oct 2015.